Udayakumar Karunakaran

Daegu, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Reductive Stress and Ferroptosis: Linking Insulin Signaling to Metabolic Dysfunction.

Reductive Stress and Ferroptosis: Linking Insulin Signaling to Metabolic Dysfunction.

Journal: Biomolecules

Published: April 17, 2026

Hydrogen sulfide: an emerging gasotransmitter involved in the survival of pancreatic islets during diabetes therapy.

Hydrogen sulfide: an emerging gasotransmitter involved in the survival of pancreatic islets during diabetes therapy.

Journal: Medical gas research

Published: August 13, 2024

Mitochondrial ALDH2 improves ß-cell survival and function against doxorubicin-induced apoptosis by targeting CK2 signaling.

Mitochondrial ALDH2 improves ß-cell survival and function against doxorubicin-induced apoptosis by targeting CK2 signaling.

Journal: Journal of diabetes investigation

Published: January 04, 2024

Mitochondrial aldehyde dehydrogenase-2 coordinates the hydrogen sulfide - AMPK axis to attenuate high glucose-induced pancreatic β-cell dysfunction by glutathione antioxidant system.

Mitochondrial aldehyde dehydrogenase-2 coordinates the hydrogen sulfide - AMPK axis to attenuate high glucose-induced pancreatic β-cell dysfunction by glutathione antioxidant system.

Journal: Redox biology

Published: October 25, 2023

Perfluorooctane sulfonate-induced oxidative stress contributes to pancreatic β-cell apoptosis by inhibiting cyclic adenosine monophosphate pathway: Prevention by pentoxifylline.

Perfluorooctane sulfonate-induced oxidative stress contributes to pancreatic β-cell apoptosis by inhibiting cyclic adenosine monophosphate pathway: Prevention by pentoxifylline.

Journal: Environmental pollution (Barking, Essex : 1987)

Published: October 16, 2022

Ferroptosis Signaling in Pancreatic β-Cells: Novel Insights & Therapeutic Targeting.

Ferroptosis Signaling in Pancreatic β-Cells: Novel Insights & Therapeutic Targeting.

Journal: International journal of molecular sciences

Published: September 29, 2022

c-Abl tyrosine kinase inhibition attenuate oxidative stress-induced pancreatic β-Cell dysfunction via glutathione antioxidant system.

c-Abl tyrosine kinase inhibition attenuate oxidative stress-induced pancreatic β-Cell dysfunction via glutathione antioxidant system.

Journal: Translational research : the journal of laboratory and clinical medicine

Published: December 25, 2021

NADPH Oxidase (NOX) Targeting in Diabetes: A Special Emphasis on Pancreatic β-Cell Dysfunction.

NADPH Oxidase (NOX) Targeting in Diabetes: A Special Emphasis on Pancreatic β-Cell Dysfunction.

Journal: Cells

Published: May 15, 2021

CD36 Signal Transduction in Metabolic Diseases: Novel Insights and Therapeutic Targeting.

CD36 Signal Transduction in Metabolic Diseases: Novel Insights and Therapeutic Targeting.

Journal: Cells

Published: April 30, 2021

Pioglitazone-induced AMPK-Glutaminase-1 prevents high glucose-induced pancreatic β-cell dysfunction by glutathione antioxidant system.

Pioglitazone-induced AMPK-Glutaminase-1 prevents high glucose-induced pancreatic β-cell dysfunction by glutathione antioxidant system.

Journal: Redox biology

Published: April 12, 2021

High glucose-induced PRDX3 acetylation contributes to glucotoxicity in pancreatic β-cells: Prevention by Teneligliptin.

High glucose-induced PRDX3 acetylation contributes to glucotoxicity in pancreatic β-cells: Prevention by Teneligliptin.

Journal: Free radical biology & medicine

Published: May 14, 2020

The Role of CD36 in Type 2 Diabetes Mellitus: β-Cell Dysfunction and Beyond.

The Role of CD36 in Type 2 Diabetes Mellitus: β-Cell Dysfunction and Beyond.

Journal: Diabetes & metabolism journal

Published: March 06, 2020

Showing 1-12 of 21

Last Updated: 09/26/2026